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BRIEF CLINICAL REPORTSThyroid storm after coronary artery bypass graftingLawrence T. Bish, PhD, Joseph E. Bavaria, MD, and John Augoustides,MD, FASE, FAHA, Philadelphia, PaWe describe a 45-year-old woman with thyroid storm devel-
oping after urgent coronary artery bypass grafting (CABG).
The hallmark clinical features included fever, tachycardia,
depressed mental status, and jaundice. Thyroid testing con-
firmed severe hyperthyroidism caused by Graves disease.
The patient was rendered euthyroid after initiation of therapy
with methimazole (INN, thiamazole), potassium iodide, and
hydrocortisone.
CLINICAL SUMMARY
A 45-year-old female recent immigrant from India came to
the emergency department with a report of severe epigastric
pain. Other than smoking, she had no history of coronary risk
factors or previous cardiovascular disease. The patient took
no regularmedicationand denied exposure to any tranquilizers.
Shewas noted to be afebrilewith a baseline sinus tachycardia of
114 beats/min and a blood pressure of 85/56mmHg.No goiter
was detected at that time. Results of the rest of the physical ex-
amination were nonspecific. Her electrocardiogram showed
anterior ST depression. Her serum troponin level was 10 times
normal. Transthoracic echocardiography demonstrated mild
global systolic dysfunction with an ejection fraction of 45%
and mild global hypokinesis. Subsequent coronary angiogra-
phy demonstrated significant stenoses of the left anterior de-
scending and circumflex coronary arteries.
On the basis of these findings, the patient underwent ur-
gent CABG with cardiopulmonary bypass. The patient
was not febrile intraoperatively. The maximal patient tem-
perature during surgery was 36.8C. The 2 coronary artery
grafts were a left internal thoracic artery to the left anterior
descending coronary artery and a saphenous vein graft
from the ascending aorta to the circumflex coronary artery.
Intraoperative transesophageal echocardiography demon-
strated severe left ventricular systolic dysfunction, with an
ejection fraction of 20%, as the result of hypokinesis of the
septum, apex, and anterior wall. The working diagnosis, in
light of the echocardiographic findings, for the new left ven-
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The Journal of Thoracic and Cabypass was ischemia in the left anterior descending coronary
artery territory. The left internal thoracic arterial graftwas care-
fully examined and judged to be adequate. The etiology of the
ischemiawas assessed as embolic (air, atheromatous debris, or
both). Therewas no significant valvular heart disease. The aor-
tic valve was mildly thickened, with trace regurgitation. There
was mild mitral and tricuspid regurgitation. The severe left
ventricular dysfunction was managed successfully with ino-
tropic support and intra-aortic balloon counterpulsation.
The onset of fever was first noted several hours postoper-
atively in the intensive care unit, with a peak of 39.6C. In
addition to the severe fever, the postoperative course was
rapidly complicated within 72 hours by depressed mental
status (Glasgow coma scale sore of 6/15), sinus tachycardia
(range, 140–160 beats/min), and progressive jaundice (peak
serum bilirubin 3 times normal). The patient remained
mildly vasodilated, with a blood pressure of 98/54 mm Hg
and a systemic vascular resistance in the low normal range
while receiving low-dose norepinephrine. Intra-aortic bal-
loon counterpulsation was discontinued because the cardiac
index was at this point 3-fold the normal value. Postopera-
tive transthoracic echocardiography on the fifth postopera-
tive day demonstrated a return to the preoperative
baseline, namely mild global systolic dysfunction with an
ejection fraction of 45% and mild global hypokinesis.
The patient had no muscle rigidity. No source of infection
could be identified. Thyroid function tests demonstrated se-
vere hyperthyroidism with significantly elevated thyroid
hormone levels and a thyroid-stimulating hormone level
a 25th of normal. A goiter was not detected on perioperative
physical examination, even by the consulted endocrinolo-
gist. A very mildly enlarged thyroid was demonstrated dur-
ing thyroid ultrasonography, which was performed as soon
as the results of the thyroid function tests became available.
On the basis of the clinical presentation, this patient had
a calculated Burch–Wartofsky thyrotoxic crisis score of
100 (a score greater than 60 is consistent with thyroid
storm).1 A diagnosis of postoperative thyroid storm was
made. Urgent endocrine consultation was obtained to guide
emergency thyroid suppression. Therapy was commenced
immediately with potassium iodide and methimazole
through a nasogastric tube, as well as high-dose hydrocorti-
sone intravenously. At this point, b-blockade was not com-
menced because the patient was still vasopressor
dependent.2 A significant hemodynamic response to thyroid
suppression therapy was evident within 48 hours, as outlined
in Table 1. The patient had strongly positive test results for
antibodies to thyroid peroxidase and the thyroid-stimulating
hormone receptor. This antibody profile was compatible
with the diagnosis of Graves disease.rdiovascular Surgery c Volume 140, Number 5 e67
TABLE 1. Changes in vital signs during management of thyroid storm
Variable
Preoperative
baseline CTICU d 1 CTICU d 2 CTICU d 3 CTICU d 4, Rx d 1 CTICU d 5, Rx d 2 CTICU d 6, Rx d 3
Temperature (C) 36.8 39.2 39.6 39.5 38.5 38.5 37.1
Heart rate (beats/min) 114 142 148 128 138 85 94
Blood pressure (mm Hg) 85/56 97/54 100/55 90/44 117/46 132/50 146/56
Norepinephrine requirement No Yes Yes Yes Weaning begun No No
CTICU, Cardiothoracic intensive care unit; Rx, thyroid suppression therapy.
Brief Clinical ReportsSubsequently, the potassium iodide was discontinued and
the hydrocortisone was tapered during the next 5 days. The
methimazole was progressively adjusted to maintenance
levels on the basis of serial thyroid function tests that dem-
onstrated a gradual return to normal. The patient’s depressed
mental status and jaundice also progressively resolved com-
pletely. The remainder of her hospital stay was uncompli-
cated. The patient remained euthyroid as an outpatient
with a methimazole maintenance regimen.DISCUSSION
Thyroid storm is a rare but life-threatening complication
of thyrotoxicosis that in this case was precipitated by cardiac
surgery.1-3 Thyroid storm is characterized by fever, altered
mental status, gastrointestinal dysfunction, tachycardia,
and high-output cardiac failure.1-3
In this report, we have described a case of thyroid storm
after CABG in a 45-year-old female patient with no known
history of either thyroid or coronary artery disease. Thyroid
storm was diagnosed according to the Burch–Wartofsky cri-
teria.1 This set of diagnostic criteria assesses the likelihood of
thyroid storm by scoring clinical features such as body tem-
perature, central nervous system effects, gastrointestinal or
hepatic dysfunction, heart rate, heart failure, atrial fibrilla-
tion, and precipitant history. The scale ranges from 0 to
140 points, with a score greater than 60 being highly compat-
ible with thyroid storm.1 The final diagnosis was based not
only on this score but also on thyroid function tests and re-
sponse to therapy.
Thyroid storm must be distinguished from other causes of
hypermetabolic postoperative states, such as sepsis,malignant
hyperthermia, and neuroleptic malignant syndrome.4,5 In our
case, although there was no exposure to neuroleptic medica-
tions, there was intraoperative exposure to volatile anesthesia,
a known trigger for malignant hyperthermia.4 The absence of
muscle rigidity and hypertension, however, made malignant
hyperthermia unlikely. Sepsis was unlikely as well in our
case, given the onset within 24 hours after surgery and the ab-
sence of a source. Furthermore, in our case thyroid storm was
suspected because of the hypermetabolic state characterized
hemodynamically by tachycardia, a high cardiac output, and
systemic vasodilation, requiring norepinephrine therapy.1-3
These features probably contributed to our patient’s postoper-
ative hemodynamic instability, because thyroid suppression
therapy restored hemodynamic stability within 48 hours.e68 The Journal of Thoracic and Cardiovascular SurgThyroid storm has been reported once previously after
CABG.6 Our case has multiple features in common with
the previous report, such as female sex, few risk factors for
coronary artery disease, minimal preoperative evidence of
thyrotoxicosis, and postoperative storm complicated by
coma and a prompt response to thyroid suppression therapy.6
The recognized triggers for thyroid storm include trauma,
pregnancy, and infection.1-3 It is likely that the trauma of car-
diac surgery triggered thyroid storm in this patient, who dis-
played no overt features of hyperthyroidism before the
operation. This diagnosis is based on the assumption that
subclinical hyperthyroidism was present before surgery, al-
though in retrospect, the patient’s tachycardia on admission
may have been a sign of hyperthyroidism that was missed.
Standard therapy for thyroid storm is multimodal.1-3,7 A
thioamide such as methimazole blocks the synthesis of thy-
roid hormone in the thyroid. Iodine therapy suppresses re-
lease of thyroid hormone through the Wolff–Chaikoff
effect. Hydrocortisone therapy blocks peripheral conversion
of thyroxine to triiodothyronine. In hemodynamically stable
patients, b-blockade is useful to counteract the increased ad-
renergic tone observed in thyroid storm.
It is important to note that thyrotoxicosis may be associated
with severe coronary spasm that may not necessarily resolve
with aggressive medical management and may require
CABG.6-9 In our patient, there was no coronary spasm de-
tected during coronary angiography. A probable explanation
is that the non–ST elevation myocardial infarction was pre-
cipitated by the excessive myocardial oxygen demand as a re-
sult of the patient’s preoperative hyperthyroidism in the
setting of significant coronary stenoses. Unfortunately, we
do not have preoperative thyroid function tests to support
this hypothesis, but it is highly likely, as evidenced by the
postoperative course. The diagnostic criteria for thyroid storm
were not satisfied until after CABG had been performed.
In summary, we have described here thyroid storm after
urgent CABG in a 45-year-old woman with a subsequent di-
agnosis of Graves disease. Although rare, this postoperative
complication is important because it is life-threatening and
yet eminently treatable.References
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Nagasaki, and Kanagawa, JapanEpidermal growth factor receptor (EGFR) tyrosine kinase
inhibitor (EGFR-TKI) gefitinib has dramatic efficacy in
more than 70% of advanced non–small cell lung cancers
with EGFR gene mutations.1 Some patients with inoperable
systemic non–small cell lung cancers demonstrate a down-
staging of their cancer to operable disease status after gefiti-
nib treatment. Despite high response rates for EGFR mutant
tumors, the median time to progression is about 1 year.1 The
EGFR T790M mutation and MET amplification are thought
to be the underlying mechanisms of the acquired resistance
to EGFR-TKIs. When complete resection of residual disease
is possible, the patients can then be considered disease free.
We have aggressively performed salvage lung resections for
patients with gefitinib responses and demonstrated down-
staging to N0M0. The purpose of this study was to assessFIGURE 1. A, Overall survival curve of patients who underwent surgical
resection after response to gefitinib administration. Median overall survival
after surgery was 32 months. B, Recurrence-free survival curve of patients
who underwent surgical resection after response to gefitinib administration.
Median recurrence-free survival after surgery was 6 months.
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